Our research aims to advance AI while developing methods that enable new discoveries in biology and medicine. We design machine learning approaches for complex, heterogeneous, and multimodal biomedical data, with an emphasis on models that can generalize beyond the settings observed during training. We also seek to understand when and why AI models fail, using these failure modes to uncover limitations of current methods and guide the development of more robust and generalizable learning principles. Alongside advancing fundamental AI research, we apply these methods to challenging problems in biomedicine, with the goal of revealing novel biological insights.

Advancing machine learning research

Our machine learning research aims to advance the capabilities and our understanding of modern AI systems. We develop methods that enable foundation models to adapt and generalize with limited or no supervision. We study multimodal AI, seeking to understand how representations across different modalities relate and how to effectively align models across different modalities. Across these directions, we investigate the capabilities, limitations, and failure modes of modern AI systems, using these insights to develop more robust and generalizable learning principles.

Advancing biomedical research

We use our methods to unravel new biological insights and work on transformative applications of machine learning in biomedicine. We are especially interested in using our methods for the analysis and understanding of high throughput single-cell data which provides unprecedented resolution to examine cell heterogeneity in tissues and organs. Our methods have been used to annotate global cell atlas consortia efforts aiming at creating comprehensive reference maps of all cell types such as HuBMAP and Fly Cell Atlas. Our lab is part of the ImmGen group and CIFAR Multiscale Human Program. We intensively collaborate with biologists, neuroscientists and medical researchers on cutting-edge problems across fields and disciplines.